Literature DB >> 526463

Management of acute closed-angle glaucoma with miotics and timolol.

P J Airaksinen, K M Saari, T J Tiainen, E A Jaanio.   

Abstract

The hypotensive effect of intramuscular or intravenous acetazolamide with frequent instillation of 2% or 4% pilocarpine in polyvinyl alcohol, or with single drops of pilocarpine in polyvinyl alcohol or oily vehicles, and the hypotensive effect of topical timolol alone and together with pilocarpine was investigated in the treatment of acute closed-angle glaucoma in 75 patients (81 eyes). The results showed that there was no marked difference in the hypotensive effect whether pilocarpine was used frequently or in a single dose, in different concentrations, or in different vehicles after acetazolamide. Topical timolol alone was not effective enough to control the intraocular pressure in acute closed-angle glaucoma, but a good hypotensive effect was seen when topical timolol was followed by pilocarpine. It is concluded that 1 drop of pilocarpine 3 hours after intravenous or intramuscular acetazolamide or after topical timolol may be sufficient to terminate an acute attack. Topical timolol may serve as a valuable alternative when systemic medication is contraindicated.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 526463      PMCID: PMC1043635          DOI: 10.1136/bjo.63.12.822

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  17 in total

1.  Miotics in closed-angle glaucoma.

Authors:  F Ganias; R Mapstone
Journal:  Br J Ophthalmol       Date:  1975-04       Impact factor: 4.638

2.  SYSTEMIC PILOCARPINE TOXICITY FROM OVERDOSAGE IN TREATMENT OF AN ATTACK OF ANGLE-CLOSURE GLAUCOMA.

Authors:  E EPSTEIN; I KAUFMAN
Journal:  Am J Ophthalmol       Date:  1965-01       Impact factor: 5.258

3.  Glaucoma treatment with timolol.

Authors:  E Kerty; I Hørven
Journal:  Acta Ophthalmol (Copenh)       Date:  1978-10

4.  An increased effect of pilocarpine on the pupil by application of the drug in oil.

Authors:  S A Smith; S E Smith; R Lazare
Journal:  Br J Ophthalmol       Date:  1978-05       Impact factor: 4.638

5.  The long-term hypotensive effect of timolol maleate compared with the effect of pilocarpine in simple and capsular glaucoma.

Authors:  P J Airaksinen
Journal:  Acta Ophthalmol (Copenh)       Date:  1979-06

6.  Timolol. A beta-adrenergic blocking agent for the treatment of glaucoma.

Authors:  T J Zimmerman; H E Kaufman
Journal:  Arch Ophthalmol       Date:  1977-04

7.  Clinical trial comparing timolol ophthalmic solution to pilocarpine in open-angle glaucoma.

Authors:  W P Boger; R F Steinert; C A Puliafito; D Pavan-Langston
Journal:  Am J Ophthalmol       Date:  1978-07       Impact factor: 5.258

8.  Effect of vehicle on pilocarpine-induced ocular hypotension.

Authors:  M Saari; P Koskela; S E Masar
Journal:  Acta Ophthalmol (Copenh)       Date:  1978

9.  Effect of vehicle on pilocarpine-induced miosis.

Authors:  M Saari; P Koskela; S E Masar
Journal:  Acta Ophthalmol (Copenh)       Date:  1978

10.  The mechanism of timolol in lowering intraocular pressure. In the normal eye.

Authors:  R L Coakes; R F Brubaker
Journal:  Arch Ophthalmol       Date:  1978-11
View more
  4 in total

1.  The Flowers report: a personal view.

Authors:  H Ellis
Journal:  Br Med J       Date:  1980-03-08

2.  Efficacy and safety of intravenous injection of lidocaine in the treatment of acute primary angle-closure glaucoma: a pilot study.

Authors:  Xiuming Jin; Anquan Xue; Yune Zhao; Qin Qin; Xiang-Da Eric Dong; Jia Qu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-04-17       Impact factor: 3.117

3.  Opposing effects of atropine and timolol on the color and luminance emmetropization mechanisms in chicks.

Authors:  Laura A Goldberg; Frances J Rucker
Journal:  Vision Res       Date:  2016-03-19       Impact factor: 1.886

4.  NELL2-Robo3 complex structure reveals mechanisms of receptor activation for axon guidance.

Authors:  Joseph S Pak; Zachary J DeLoughery; Jing Wang; Nischal Acharya; Yeonwoo Park; Alexander Jaworski; Engin Özkan
Journal:  Nat Commun       Date:  2020-03-20       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.